LongeVC is an international venture capital firm investing in an ageless future. Through supporting exceptional early stage founders, our mission is to bring breakthrough biotech to market — the science that will change lives and transform our health.
We are curating an ecosystem of biotech and longevity-focused companies that are changing the world. We connect founders with a global network of thought leaders for an ageless future.
Pre-clinical and clinical stage drug development companies exploring the underlying molecular and cellular mechanisms of aging.
Early-stage companies developing new solutions to enable personalized medicine and advanced diagnostics.
Foundational platform technologies and integrated healthcare solutions enabling faster drug discovery and testing at scale.